An overview of various aspects of the supply chain that would be crucial in the production and distribution of COVID-19 Vaccine. Write to us at connect@pharmashots.com if you want a PDF copy of this report. Over the past seven months, the global pandemic caused by the spread of SARS-CoV-2, the virus that leads to coronavirus […]Read More
Shots: PharmaShots started its journey in July 2018 as a concise news delivery service and is proud to announce the completion of two years, with many more to come. Till now, PharmaShots has published 3,057 posts delivered to our 3000+ subscribers On the 2nd anniversary, PharmaShots announced “PharmaShots Bespoke” its new tailor-made, and targeted news […]Read More
The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care. The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 13 novel products so far in 2020, including 10 in Feb and 3 in Jan […]Read More
1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date – Oct 01, 2019 Product – Zirabev (biosimilar, bevacizumab) The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept […]Read More
Shots: May all the sweet magic of Christmas conspire to gladden your heart and fill every desire We would like to Thank You all for your sincerest appreciation and concern as well as your trust you have shown to us Wishing you a season of joy and looking forward to continued success in 2020 and […]Read More
The third quarter of 2019 has ended with major acquisitions in the pharma and biotech industry along with multiple approvals. Starting with the latest acquisition where Biocon Biologics acquires Pfizer’s Research Facility for expansion of its R&D footprints with the acceleration of the development of its biosimilars from lab to pilot scale. Previously, Amgen acquired […]Read More
Shots: Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to come. PharmaShots has published 1,238 news and articles till date We are grateful to all our subscribers for their affection towards PharmaShots and for subscribing our news alerts. We ensure to put […]Read More
The second quarter of 2019 has ended with major acquisitions in pharma and biotech industry. Moving with the latest acquisition of Allergan for $63B by AbbVie focusing on to generate revenue with addition of Allergan’s medical aesthetics and ophthalmology portfolio. Prior to that, Pfizer acquired Array Biopharma for $11.4B to expand its oncology portfolio. Some […]Read More
Shots: Team PharmaShots proudly announce that we are awarded as Top 50 Pharma Blog by Feedspot We are thankful to Feedspot for identifying our efforts and awarding us with this honor. We will continue to put our effort to provide the latest news available to our subscribers PharmaShots, a Division of Octavus Consulting, which provides […]Read More
Copyright ©2020 PharmaShots | Powered by Octavus Consulting
